2012
DOI: 10.1038/nsmb.2273
|View full text |Cite
|
Sign up to set email alerts
|

Human prion protein binds Argonaute and promotes accumulation of microRNA effector complexes

Abstract: Despite intense research in the context of neurodegenerative diseases associated with its misfolding, the endogenous human prion protein PrP(C) (or PRNP) has poorly understood physiological functions. Whereas most PrP(C) is exposed to the extracellular environment, conserved domains result in transmembrane forms of PrP(C) that traffic in the endolysosomal system and are linked to inherited and infectious neuropathologies. One transmembrane PrP(C) variant orients the N-terminal 'octarepeat' domain into the cyto… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
40
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 43 publications
(40 citation statements)
references
References 51 publications
0
40
0
Order By: Relevance
“…As illustrated earlier for P-miRISC in Drosophila , the binding of AGO to Loqs-PB and GW182 is mutually exclusive [34], suggesting that altered compositions of miRISCs result in distinct functional consequences [4,11,35,36]. For example, AGO was recently shown to bind to the human prion protein PrP C [37]; this is the protein that, when misfolded, causes neurological pathologies, including variant Creutzfeldt–Jakob disease. PrP C co-fractionates with miRISC components on endosomes, including MVBs [27], and its binding to AGO promotes the formation or stability of GW182-containing miRISC [37].…”
Section: New Ago Partners and Non-ago Mirna-binding Proteinsmentioning
confidence: 99%
See 1 more Smart Citation
“…As illustrated earlier for P-miRISC in Drosophila , the binding of AGO to Loqs-PB and GW182 is mutually exclusive [34], suggesting that altered compositions of miRISCs result in distinct functional consequences [4,11,35,36]. For example, AGO was recently shown to bind to the human prion protein PrP C [37]; this is the protein that, when misfolded, causes neurological pathologies, including variant Creutzfeldt–Jakob disease. PrP C co-fractionates with miRISC components on endosomes, including MVBs [27], and its binding to AGO promotes the formation or stability of GW182-containing miRISC [37].…”
Section: New Ago Partners and Non-ago Mirna-binding Proteinsmentioning
confidence: 99%
“…For example, AGO was recently shown to bind to the human prion protein PrP C [37]; this is the protein that, when misfolded, causes neurological pathologies, including variant Creutzfeldt–Jakob disease. PrP C co-fractionates with miRISC components on endosomes, including MVBs [27], and its binding to AGO promotes the formation or stability of GW182-containing miRISC [37]. Alternatively, most AGO-bound miRNAs in adult tissues exist as low-molecular-weight complexes that are not associated with mRNA and GW182 [2]; these miRNAs are not actively engaged in target repression, but may act as miRNA reservoirs instead [2].…”
Section: New Ago Partners and Non-ago Mirna-binding Proteinsmentioning
confidence: 99%
“…Cells were prepared for microscopy as previously described 4,43 . Cells were grown on 0.17-mm glass coverslips overnight before fixation in 2% paraformaldehyde in PBS (10 min).…”
Section: Methodsmentioning
confidence: 99%
“…In flies and humans, AGO subfamily proteins are reported to localize at non-membranous bodies such as P-bodies and/or membranous organelles such as endoplasmic reticulum (ER), multivesicular bodies (MVBs) and Golgi [161][162][163][164][165][166][167][168][169][170][171][172][173][174][175][176][177][178][179][180].…”
mentioning
confidence: 99%